/
Your selections:
Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer
- Scurry, James, van Zyl, Belinda, Gulliver, Damien, Otton, Geoffrey, Jaaback, Kenneth, Lombard, Janine, Vilain, Ricardo E., Bowden, Nicola A.
Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
- Bowden, Nikola A.
Are you sure you would like to clear your session, including search history and login status?